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SUMMARY – Liposarcoma of the spermatic cord is a malignant tumor so rare that there are less 
than 200 cases reported in the literature worldwide. Liposarcoma is a malignancy which originates 
from fat tissue. Although only 3%-7% of all paratesticular sarcomas primarily arise from structures of 
the spermatic cord, clinical significance of these tumors must not be neglected because they are often 
preoperatively misdiagnosed. A 66-year-old male presented with a painless swelling on the left side of 
the scrotum. Local examination revealed a solid, smooth, limited mass of approximately 4x3 cm in the 
left side of the scrotum. Tumor markers were within the reference range. Ultrasound examination 
showed a solid, clearly limited non-homogeneous mass of 40x20 mm localized in the left spermatic 
cord. Magnetic resonance imaging showed an expansive mass measuring 60x85x60 mm in the left 
inguinoscrotal region without propagation into the abdominal cavity. Both testicles and epididymides 
appeared normal on magnetic resonance examination and no locoregional enlarged lymph nodes were 
seen. The patient was treated operatively with radical inguinal orchiectomy. In conclusion, liposarco-
mas of the spermatic cord are extremely rare neoplasms that clinically present as slow-growing, pain-
less, palpable inguinal or scrotal masses. Radical orchiectomy with high ligation of the spermatic cord 
and wide excision of the surrounding soft tissues within the inguinal canal remains the gold standard 
treatment option. Recurrence of the disease is frequent even several years after primary therapy, there-
fore long-term follow-up is mandatory.
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Introduction
Liposarcoma is a malignant tumor that originates 
from mesenchymal cells and represents the most com-
mon type of primary malignant tumor of the spermat-
ic cord1. Paratesticular liposarcomas are very rare con-
ditions and there are less than 200 cases reported in 
the literature to date. Most of these tumors manifest 
as painless, slow-growing scrotal or inguinal masses. 
Given their rare occurrence, spermatic cord liposarco-
mas are often misdiagnosed as inguinoscrotal hernias, 
hydrocele, lipomas, funicular cysts or testicular tu-
mors2. Regarding the rarity of these malignancies, 
there is little information on liposarcomas and no of-
ficial recommendations and guidelines for diagnosis, 
treatment and follow-up of these patients. These limi-
tations have led to the lack of consensus on optimal 
surgical and adjuvant treatment3,4.
Case Report
A 66-year-old male presented with a painless scro-
tal mass on the left side. The patient reported that he 
had noticed painless scrotal mass about 6 months be-
fore, growing progressively ever since. Physical exami-
nation revealed a solid, smooth-surfaced mass measur-
ing 4x3 cm on the left side of the scrotum. Tumor 
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markers (human chorionic gonadotropin, alpha-feto-
protein and lactate dehydrogenase) were within the 
reference range. Scrotal ultrasonography revealed an 
oval, clearly limited, inhomogeneous mass of 40x20 
mm within the left spermatic cord. Testicle and epi-
didymis showed no pathologic abnormalities. Mag-
netic resonance imaging (MRI) showed an expansive 
mass measuring 60x85x60 mm in the left inguinoscro-
tal region, which was T2W hypodense and T1W hy-
perdense. There were no MRI signs of mass propaga-
tion to the abdominal cavity. Testicle and epididymis 
on both sides appeared normal on MRI examination. 
No enlarged locoregional lymph nodes were found.
differentiated liposarcoma of the spermatic cord and 
adenomatous hyperplasia of rete testis.
Six months following the surgery, MRI showed no 
signs of tumor recurrence and enlarged pelvic lymph 
nodes.
The patient provided informed consent for the in-
formation presented here to be shared.
Discussion
In the adult population, more than 75% of primary 
paratesticular tumors arise from the spermatic cord. 
Fig. 1. Magnetic resonance image of the scrotum showing 
liposarcoma of the left spermatic cord.
Based on clinical and radiological findings, surgical 
exploration of the spermatic cord and scrotum was 
performed using inguinal approach. The left spermatic 
cord was dissected and a yellow, multilobulated mass 
measuring 9x7 cm was found.
The mass involved the entire circumference of the 
spermatic cord and was descending into the scrotum, 
surrounding the testicle. Testicle and epididymis ap-
peared normal with no signs of tumor infiltration. 
Based on MRI and intraoperative findings, it was de-
cided to perform radical orchiectomy with high liga-
tion of the spermatic cord. Postoperative course was 
uneventful and the patient was discharged on postop-
erative day 4. Histopathologic finding showed well-
Fig. 2. Intraoperative finding showing bivalved 
spermatic cord liposarcoma.
Fig. 3. Well-differentiated (lipoma-like) liposarcoma 
with sclerosing areas and numerous lipoblasts  
(HE, X200).
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Most authors agree that sarcomas primarily originate 
from mesodermal tissue rather than due to malignant 
transformation of benign lipomatous tissue5. Primary 
spermatic cord malignancies usually originate below 
the external inguinal ring and therefore present more 
often as scrotal masses than inguinal masses. Difficul-
ties in diagnosing these tumors are due to the fact that 
more frequent conditions manifest themselves as pain-
less scrotal masses. Therefore, spermatic cord liposar-
comas are often misdiagnosed as inguinoscrotal her-
nias, lipomas, hydrocele, epididymal cysts, or testicular 
tumors6,7. Most spermatic cord liposarcomas are well 
differentiated, low-grade malignancies with no or 
minimal tendency to metastasize. Liposarcomas are 
locally aggressive tumors with a high incidence of local 
recurrence8.
Considering the numerous pathologic conditions 
in the differential diagnosis of scrotal masses, first-line 
examination should be ultrasound (US). The usual US 
presentation of spermatic cord liposarcoma is a hetero-
geneous and hypervascular mass with hyperechoic ar-
eas that represent different amounts of fat inside the 
tumor9,10. Although US can provide useful informa-
tion regarding location, size and consistency of the 
mass, there are no pathognomonic sonographic fea-
tures that can differentiate benign from malignant le-
sions, so additional imaging is often necessary11,12.
Computerized tomography (CT) and MRI are su-
perior imaging diagnostic tools which can be more 
helpful in assessing the exact size, location and consis-
tency of tumor, as well as evaluating the status of sper-
matic cord and testicle. According to some authors, 
these diagnostic methods may be helpful in narrowing 
the differential diagnosis by suggesting fat-containing 
tumors such as liposarcomas13. Definite diagnosis is 
usually made after histopathologic examination, con-
sidering that primary spermatic cord tumors do not 
show specific radiographic signs or patterns4.
General recommendations for treatment are based 
on case reports and small series due to the rare occur-
rence of these tumors4. Radical orchiectomy with high 
ligation of the cord and wide tumor resection with no 
microscopic positive margins is the essential element 
in surgical management of primary spermatic cord 
malignancies13,14.
Some authors consider that local recurrence of 
these tumors is more likely a consequence of incom-
plete excision rather than differentiation level, histo-
logic type and tumor size15,16. In addition, the tendency 
of sarcomas to infiltrate local structures significantly 
increases the difficulty to complete radical resection, 
and positive margins can actually promote tumor seed-
ing through the operative site17.
A recent publication by Coleman et al.15 proposes 
extensive en bloc excisions of all surrounding tissues 
that are potentially infiltrated and re-excision in case 
of local recurrence. They have reported that nearly 
one-third of the patients without clinically manifest 
disease who underwent re-excision were found to have 
residual tumor. A decrease in the local recurrence rate 
and improvement in disease-free survival was shown 
in patients having undergone reoperative wide exci-
sion after prior incomplete resection15. Other authors 
showed long disease-free periods after simple tumor 
excision without radical surgical approach such as rad-
ical orchiectomy18. Regardless of the above, radical or-
chiectomy with high spermatic cord ligation is consid-
ered the gold standard treatment for spermatic cord 
liposarcomas according to most authors.
The role of adjuvant radiation therapy and chemo-
therapy for treatment of spermatic cord sarcomas has 
not been well established4,15. However, due to the high 
risk of local recurrence following surgery, there is in-
creasing evidence that all spermatic cord tumors re-
gardless of histologic type and grade should receive 
adjuvant radiotherapy. Therefore, the most suitable 
treatment option might be a multimodality approach 
including radical orchiectomy and adjuvant radiother-
apy. Spermatic cord sarcomas have shown resistance to 
chemotherapy, so routine systematic chemotherapy is 
not recommended19,20. In addition to all the above, it is 
important to point out that there is an increasing inci-
dence of testicular cancer in our country, as well as in 
neighboring countries21.
Conclusion
Liposarcomas of the spermatic cord are very rare 
malignant tumors, and therefore they are often preop-
eratively misdiagnosed. Liposarcomas present locally 
aggressive malignancies and show a high incidence of 
local recurrence. There is no general consensus regard-
ing proper treatment and management of the disease. 
Radical orchiectomy with high ligation of the cord 
and wide tumor resection with no microscopic positive 
margins is the most recommended treatment option 
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according to most authors. The role of adjuvant radia-
tion therapy and chemotherapy in the treatment of 
spermatic cord sarcomas still remains controversial. 
Long-term patient follow-up is mandatory because 
local recurrence of the spermatic cord liposarcomas is 
common even several years after primary therapy.
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Sažetak
LIPOSARKOM SJEMENSKE VRPCE – DIJAGNOSTIČKI I TERAPIJSKI IZAZOV
D. Jeremić, M. Maletin, S. Vojinov, I. Levakov, D. Grbić, T. Lakić i S. Trivunić Dajko
Liposarkom sjemenske vrpce je toliko rijedak maligni tumor da je do sada opisano manje od 200 slučajeva u literaturi. 
Liposarkom je malignitet koji vodi podrijetlo od masnog tkiva. Iako samo 3%-7% svih paratestikularnih sarkoma primarno 
potječe od struktura sjemene vrpce, kliničko značenje ovih tumora ne smije se zanemariti, jer ih se često prijeoperacijski 
pogrešno dijagnosticira. U radu je prikazan bolesnik u dobi od 66 godina s kliničkom slikom bezbolne tumefakcije hemiskro-
tuma s lijeve strane. Lokalni nalaz je ukazivao na solidnu, glatku, jasno ograničenu masu veličine oko 4x3 cm u lijevom he-
miskrotumu. Vrijednosti tumorskih biljega bile su unutar referentnih vrijednosti. Na ultrazvučnom pregledu opisana je solid-
na, jasno ograničena nehomogena masa dimenzija 40x20 mm u lijevoj sjemenoj vrpci. Magnetska rezononacija abdomena i 
zdjelice pokazala je ekspanzivnu masu u lijevoj ingvinoskrotalnoj regiji veličine oko 60x85x60 mm bez znakova propagacije 
u abdominalnu šupljinu. Na magnetskoj rezonanciji testisi i epididimisi su imali normalan izgled i nisu uočeni uvećani loko-
regionalni limfni čvorovi. Bolesnik je tretiran operativno, napravljena je radikalna orhiektomija ingvinalnim pristupom. U 
zaključku, liposarkomi sjemene vrpce su ekstremno rijetke neoplazme koje se klinički manifestiraju kao sporo rastuće, bez-
bolne, palpabilne ingvinalne ili skrotalne mase. Radikalna orhiektomija s visokim podvezivanjem sjemene vrpce i širokom 
ekscizijom okolnih mekih tkiva unutar ingvinalnog kanala predstavlja zlatni standard liječenja. Recidiv bolesti je čest, čak i 
nekoliko godina nakon primarnog liječenja te je dugačko razdoblje praćenja obvezatno.
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